EMA Headquarters to Move to Amsterdam
The European Medicines Agency (EMA), the EU body responsible for the evaluation of medicinal products for use…
Amgen B.V. Netherlands
Last updated: 01.06.2015
Address: Minervum 7061, 4817 ZK, Breda,Netherlands
Tel: 076-5732500
Web: http://www.amgen.nl/dutch/index.html
Company description
Sinds 1997 levert Amgen vanuit Breda haar producten door heel Europa en aan een groeiend aantal landen in andere delen van de wereld. We verpakken medicijnen landenspecifiek, slaan ze tijdelijk op en verschepen uiteindelijk naar meer dan 50 landen.
Voor Amgen Europe B.V. geldt: “Elke patiënt, telkens weer”. Hiermee bedoelen we dat we ernaar streven om onze producten altijd beschikbaar te hebben op de juiste plaats en op de juiste tijd voor de behandeling van de patiënt. Vanuit Breda distribueren we zowel geregistreerde producten als producten die gebruikt worden in klinisch onderzoek. Breda is ook de vestigingsplaats van twee onderdelen van de Global Supply Chain organisatie verantwoordelijk voor Europa, Afrika en Australië/Nieuw-Zeeland. Daarnaast is Amgen Breda het internationale centrum buiten de Verenigde Staten voor enkele andere functies, zoals Quality & Regulatory Compliance, Information Systems en Financial Shared Services.
Circa 500 gemotiveerde mensen werken samen in hun streven naar perfectie in hun werkzaamheden, met als uiteindelijke doel het verbeteren van mensenlevens.
Products and services
Amgen has marketed various key breakthrough products including Aranesp, Neulasta, Neupogen, Mimpara en Nplate all of which have made a vital contribution to patients’ welfare. Amgen’s future aims will also remain centred on finding innovative solutions for patients. This is why Amgen continues to develop new products for syndromes where treatment options are insufficient.
Related
Interview: Leo De Haan – Managing Director Benelux, Aurobindo, The…
Leo de Haan of Aurobindo discusses how to maintain a profitable business in times of rock-bottom generics prices in…
The Netherlands: A Fertile Garden for Innovation
Despite lacking a national champion to bolster its innovative eco-system since the 2007 acquisition of Organon by…
Forging the Future of Healthcare in the Netherlands
The Netherlands is clearly a fertile environment for its 2,200 life science and medtech companies. However, the…
Interview: Karel Fol – Country Manager Benelux, Sobi, The Netherlands
Sobi is a leading integrated biopharmaceutical company dedicated to developing innovative therapies and services to…
Interview: Paul Korte – General Manager, Janssen Netherlands
Paul Korte, General Manager for Janssen in the Netherlands, highlights the strategic move and leadership position…
Interview: Hans Hofstraat – Vice President, Philips Research, The…
In an exclusive interview, the Vice President of Philips Research explains the key to continuous evolution,…
Interview: Roland van Esch – Managing Director, Zimmer Biomet, The…
Healthcare is moving towards an increased level of personalization and active participation of the patient in the…
Interview: Hennie Henrichs – General Manager Benelux & Nordics, Teva,…
Teva Benelux and Nordics’ GM lifts the lid on how the company has grown to become the market leader in the…
Interview: Aarnoud Overkamp – Managing Director, Takeda Netherlands
Takeda’s goal is to become a trusted and reliable partner in the healthcare system by better understanding…
Interview: Lo Wuite – General Manager Managed Equipment Services Europe;…
In many aspects, 2016 truly marks the dawn of a new era for Toshiba Medical Systems. Lo Wuite (LW), General Manager…
Interview: Fred Westdijk – Vice President Life Sciences & Healthcare;…
DHL Supply Chain Benelux understands the challenges life sciences companies face and has developed solutions to…
